Eikon Therapeutics Targets IPO as Merck Veterans Bet on Biology
Eikon Therapeutics, a privately held biotechnology company founded by former Merck executives, has taken a decisive step toward the public markets. The high-profile startup recently filed confidential paperwork for an…